Quality of life in brain metastases radiation trials: a literature review

BACKGROUND: An estimated 20%–40% of cancer patients will develop brain metastases. Whole-brain radiotherapy (wbrt) is the standard treatment for patients with brain metastases. Although wbrt can reduce neurologic symptoms, the median survival following wbrt is between 3 and 6 months. Given this limi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wong, J., Hird, A., Kirou–Mauro, A., Napolskikh, J., Chow, E.
Format: Artigo
Idioma:Inglês
Publicat: Multimed Inc. 2008
Matèries:
E-Manuscript Article Summary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2582512/
https://ncbi.nlm.nih.gov/pubmed/19008990
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars